ML19099A211: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
 
(Created page by program invented by StriderTol)
Line 3: Line 3:
| issue date = 04/29/2019
| issue date = 04/29/2019
| title = Federal Register Notice: Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive, Draft Options for Public Comment and Public Meeting
| title = Federal Register Notice: Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive, Draft Options for Public Comment and Public Meeting
| author name = Kock A L, Lopas S L
| author name = Kock A, Lopas S
| author affiliation = NRC/NMSS/DMSST/MSEB
| author affiliation = NRC/NMSS/DMSST/MSEB
| addressee name =  
| addressee name =  

Revision as of 08:15, 12 June 2019

Federal Register Notice: Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive, Draft Options for Public Comment and Public Meeting
ML19099A211
Person / Time
Issue date: 04/29/2019
From: Andrea Kock, Sarah Lopas
NRC/NMSS/DMSST/MSEB
To:
Sarah Lopas
References
NRC-2018-0230
Download: ML19099A211 (12)


Text

  • Federal Register

A. Status Quo

  • B. Tailored Training and Experience Requirements
  • 1. Limited AU for Alpha- or Beta-Emitting Radiopharmaceuticals
  • 2. Limited AU for Unit-Dose, Patient-Ready Radiopharmaceuticals *3. Limited AU for Any One Parenteral Radiopharmaceutical
4. Emerging Radiopharmaceuticals C. Performance-Based 1. Competency-Based Evaluation *
2. Credentialing of Authorized Users
  • D. Team-Based *
1. Radiopharmaceutical Team
2. Team AUs with Authorized Administrators 3. Partner Limited-Trained AUs with Authorized Nuclear Pharmacists

/RA/